Correlation Between ASTELLAS PHARMA and Johnson Johnson

Can any of the company-specific risk be diversified away by investing in both ASTELLAS PHARMA and Johnson Johnson at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ASTELLAS PHARMA and Johnson Johnson into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ASTELLAS PHARMA UNSPADR and Johnson Johnson, you can compare the effects of market volatilities on ASTELLAS PHARMA and Johnson Johnson and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ASTELLAS PHARMA with a short position of Johnson Johnson. Check out your portfolio center. Please also check ongoing floating volatility patterns of ASTELLAS PHARMA and Johnson Johnson.

Diversification Opportunities for ASTELLAS PHARMA and Johnson Johnson

-0.18

Correlation Coefficient

ASTELLAS PHARMA  Johnson Johnson

Good diversification

The 3 months correlation between ASTELLAS and Johnson is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding ASTELLAS PHARMA UNSPADR and Johnson Johnson in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Johnson Johnson and ASTELLAS PHARMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ASTELLAS PHARMA UNSPADR are associated (or correlated) with Johnson Johnson. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Johnson Johnson has no effect on the direction of ASTELLAS PHARMA i.e., ASTELLAS PHARMA and Johnson Johnson go up and down completely randomly.

Pair Corralation between ASTELLAS PHARMA and Johnson Johnson

Assuming the 90 days trading horizon ASTELLAS PHARMA UNSPADR is expected to under-perform the Johnson Johnson. But the stock apears to be less risky and, when comparing its historical volatility, ASTELLAS PHARMA UNSPADR is 1.07 times less risky than Johnson Johnson. The stock trades about -0.02 of its potential returns per unit of risk. The Johnson Johnson is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  13,796  in Johnson Johnson on December 30, 2024 and sell it today you would earn a total of  1,362  from holding Johnson Johnson or generate 9.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ASTELLAS PHARMA UNSPADR  vs.  Johnson Johnson

ASTELLAS PHARMA UNSPADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, ASTELLAS PHARMA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Johnson Johnson

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Johnson are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Johnson Johnson may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with ASTELLAS PHARMA and Johnson Johnson

The main advantage of trading using opposite ASTELLAS PHARMA and Johnson Johnson positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ASTELLAS PHARMA position performs unexpectedly, Johnson Johnson can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Johnson Johnson will offset losses from the drop in Johnson Johnson's long position.

The idea behind ASTELLAS PHARMA UNSPADR and Johnson Johnson pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.